Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
about
GLP-1 based therapeutics: simultaneously combating T2DM and obesity.Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experienceEffects of glucagon-like peptide-1 receptor agonists on renal functionPharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.Potential side effects to GLP-1 agonists: understanding their safety and tolerability.Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus.Eosinophil-rich granulomatous panniculitis caused by exenatide injection.Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece.
P2860
Q35200252-048D0062-2190-4D28-86F2-E3E57F95438CQ36766081-B058DDE8-2B6B-45D4-B98F-28FDBF28FA5EQ37232679-BC60EB43-F1D0-4E02-8F81-C27542F26466Q38261573-6CAF9307-3656-4BA0-ACC0-7A52D98E9453Q38286444-C079361F-B90D-41DA-AFCF-6DCF0D6E3F0EQ38526870-FF538D2D-4C6B-4247-9514-D913A1A4BE10Q45759606-EB2562A2-C7CF-4B50-9528-C6B0689B36F0Q47698045-4A246D07-D715-4510-85E9-F50DEB88C2D5
P2860
Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
@en
type
label
Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
@en
prefLabel
Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
@en
P2860
P1433
P1476
Exenatide extended-release: a review of its use in type 2 diabetes mellitus.
@en
P2860
P304
P356
10.2165/11209750-000000000-00000
P577
2012-08-01T00:00:00Z
P6179
1005334045